This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Amphista Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David McGarry - Innovator in Targeted Protein Degradation
Introduction
David McGarry is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. His innovative work has led to the development of a patent that holds promise for advancing therapeutic strategies.
Latest Patents
David McGarry holds a patent titled "Compounds for Targeted Protein Degradation." This patent represents a significant advancement in the ability to selectively degrade proteins, which can have profound implications for treating various diseases.
Career Highlights
David is currently associated with Amphista Therapeutics Limited, a company focused on developing innovative therapies. His work at Amphista Therapeutics has positioned him as a key player in the biotechnology sector, contributing to groundbreaking research and development.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Giles Albert Brown and Pauline Drouhin. These collaborations have fostered a dynamic environment for innovation and have enhanced the impact of their collective research efforts.
Conclusion
David McGarry's contributions to targeted protein degradation exemplify the spirit of innovation in biotechnology. His work continues to inspire advancements in therapeutic development, showcasing the importance of collaboration and creativity in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile